InVivo Therapeutics Holdings Corp. (NVIV) Fundamentals

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
SHARE INFORMATION
Market Cap$ 12,465,277
Shares Outstanding1,391,214
Float1,390,600
Percent Float99.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -7.64
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions34
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months64,442
Institutional Holdings Percent5.1%
Institutional Sold Previous 3 Months310,653
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent49.7
Insider Sold Previous 3 Months-
Insider Shares Owned17,022,079
TRADING INFO
52 Week High$ 20.23
52 Week Low$ 3.50
52 Week High Change$ -44.25
21 Day Moving Average$ 4.3765
21 Day Extended Moving Average$ 4.7905
50 Day Moving Average$ 4.3787
50 Day Extended Moving Average$ 4.684
200 Day Moving Average$ 8.6578
200 Day Extended Moving Average$ 8.512
10 Day Average Volume4,219,175
20 Day Average Volume2,116,238
30 Day Average Volume1,413,327
50 Day Average Volume852,529
Alpha-0.108959
Beta1.3059
Standard Deviation0.249812
R20.068355
7 Day Price Change$ 4.90
7 Day Percent Change120.73%
21 Day Price Change$ 5.07
21 Day Percent Change130.33%
30 Day Price Change$ 5.10
30 Day Percent Change132.12%
Month to Date Price Change$ 4.90
Month to Date Percent Change120.73%
Quarter to Date Price Change$ 4.91
Quarter to Date Percent Change121.23%
180 Day Price Change$ -0.3175
180 Day Percent Change-3.42%
200 Day Price Change$ -3.97
200 Day Percent Change-30.72%
Year to Date Price Change$ -2.44
Year to Date Percent Change-21.42%

InVivo Therapeutics Holdings Corp. (NVIV) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio7.70
Leverage Ratio1.20
Quick Ratio7.30
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ -1,487,723
Price to Sales0.00
Price to Free Cash-1.60
PE High Last 5 Years-0.20
Price To Book0.80
Price To Cash Flow0.00
PE Low Last 5 Years-0.90
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-46.22
Return on Equity-52.13
Return on Capital-47.82

InVivo Therapeutics Holdings Corp. (NVIV) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorRSM US LLP
CEORichard M. Toselli
Emplyoees7
Last AuditUQ
CIK0001292519
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
AddressOne Kendall Square
Suite B14402
Cambridge, MA 2139
Websitehttps://www.invivotherapeutics.com
Facsimile-
Telephone+1 617 863-5500
EmailIR@invivotherapeutics.com


Your Recent History
NASDAQ
NVIV
InVivo The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.